The Color of Precision Medicine

The Color of Precision Medicine

 
Edition number: 1
Publisher: Routledge
Date of Publication:
 
Normal price:

Publisher's listprice:
GBP 130.00
Estimated price in HUF:
62 790 HUF (59 800 HUF + 5% VAT)
Why estimated?
 
Your price:

56 511 (53 820 HUF + 5% VAT )
discount is: 10% (approx 6 279 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:

Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
 
  Piece(s)

 
 
 
 
Product details:

ISBN13:9781032565583
ISBN10:1032565586
Binding:Hardback
No. of pages:160 pages
Size:234x156 mm
Weight:460 g
Language:English
Illustrations: 1 Illustrations, black & white; 1 Line drawings, black & white; 3 Tables, black & white
0
Category:
Short description:

This book proposes the concept of racialization of precision medicine, defined as the social processes by which racial/ethnic categories are incorporated (or not) into the development, interpretation and implementation of precision medicine research and practice. An important resource on how to deracialize precision medicine

Long description:

Will genome-based precision medicine fix the problem of race/ethnicity-based medicine? To answer this question, Sun and Ong propose the concept of racialization of precision medicine, defined as the social processes by which racial/ethnic categories are incorporated (or not) into the development, interpretation, and implementation of precision medicine research and practice.


Drawing on interview data with physicians and scientists in the field of cancer care, this book addresses the following questions: Who are the racializers in precision medicine, how and why do they do it? Under what conditions do clinicians personalize medical treatments in the context of cancer therapies? The chapters elucidate different ways in which racialization occurs and reveal that there exists an inherent contradiction in the usage of race/ethnicity as precision medicine moves from bench to bedside. The relative resources theory is proposed to explain that whether race/ethnicity-based medicine will be replaced by genomic medicine depends on the resources available at the individual and systemic levels. Furthermore, this book expands on how racialization happens not only in pharmacogenomic drug efficacy studies, but also in drug toxicity studies and cost-effectiveness studies.


An important resource for clinicians, researchers, public health policymakers, health economists, and journalists on how to deracialize precision medicine.

Table of Contents:

Table of Contents


 


1 . Introduction


Precision medicine (PM): A global phenomenon


What is precision medicine? Definitions, sites and scale.


Precision medicine as an alternative to race-based medicine


            What is race-based medicine and racial profiling in medicine?


            Problems with race-based medicine/racial profiling in medicine


            Is genome-based precision medicine really the answer?


   Addressing the debate: Racialization as the key concept


            Racialization of national census categories


            Racialization in science (or, scientific racism) in colonial contexts


Racialization of medicine in colonial contexts


Racialization in medicine in contemporary times


In the (post-)Genomic Era: Racialization of human genomic science


What is the future of genome-based precision medicine? An empirical examination in cancer care in three post-colonial societies.


Chapter outline



2 . Using race to overcome race: An inherent contradiction in precision medicine


Introduction


Using race to overcome race: understanding an inherent contradiction in translational precision medicin


            First domain: Searching for the genetic biomarker in scientific                  research


           Second domain: Recruiting suitable human subjects for clinical                 trials


           Third domain: Medical decision-making in the clinic


Conclusion


 


3. Trans-National colors: Race, Ethnicity and Genomic Science in the United States of America, Canada and Singapore


Introduction


Is race biological or socially constructed? A brief overview.


Where and how do racialization happen in genomic science?


Materials for racialization of a population sample and/or patient  


            Issues with the different ways of racialization 


Perspectives from the genomic science community about the                  relationship between race and genetics


            No clear distinction between ethnoracial population groups


Genetic heterogeneity within an ethnoracial population group


Race as a social construct


If race is socially constructed, why are there differences in frequencies of genetic alleles between racial/ethnic groups?


If not race, what drives human genomic diversity?


Conclusion



4. The ?relative resources? model: Heterogeneity of resources and the racialization of precision medicine


Introduction


The ?personalized medicine? versus ?racialized medicine? debate


?Race is really the poor man?s genomic test?: The relative resources model


Financial resources


Human and informatics resources


            Legal and infrastructural resources


Implications of the relative resources model


Conclusion


 


5. Pharmacogenetic/Pharmacogenomic Drug Toxicity Studies, Race/Ethnicity and Managing Adverse Drug Reactions in the Clinic: Ongoing Tensions


Introduction


Examples of racialised pharmacogenomic studies in the US, Canada and Singapore


Allopurinol


5-Fluorouracil (5-FU)


Cost-effectiveness studies, race/ethnicity and precision medicine


Who is Asian and who is Caucasian?


Debating race/ethnicity-based pharmacogenetic toxicity data in the clinic


Subjective interpretation of drug toxicity risks


Toxicity is a multi-factor phenomenon and is not just about                         genetics


Pharmacogenetics/pharmacogenomics studies and pharmaceutical companies are at odds. 


Conclusion


 


6    Conclusion


What is already known on the topics of race-based medicine, precision medicine, and the molecularization of race?


What does this book add to the existing state of the art?


What are the arguments and findings in each chapter?


How might this study affect research, practice or policy? 


            Research


Practice


Policy


Science communication by scientists and journalists


Medical education


What should different stakeholders take away from this book?


Scientists


Physicians/medical doctors


Public policy makers


Health economists


 What are the theoretical and empirical contributions of this book?


On ?racialization?


On the nexus of relative resources and racialization of precision              medicine


On differential racialization


What are the tensions with the usage of race/ethnicity in genomic science with medical and public health implications?


    What are some of the limitations of this study?


    What are some of the future research projects based on this book?